NOVALAR PHARMACEUTICALS INC has a total of 26 patent applications. Its first patent ever was published in 2001. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Canada. Its main competitors in its focus markets pharmaceuticals, machines and medical technology are ENTEC, KORTH RUTH and PHYTOTECH LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 10 | |
#2 | WIPO (World Intellectual Property Organization) | 3 | |
#3 | Canada | 2 | |
#4 | Japan | 2 | |
#5 | South Africa | 2 | |
#6 | Australia | 1 | |
#7 | Brazil | 1 | |
#8 | China | 1 | |
#9 | EPO (European Patent Office) | 1 | |
#10 | Mexico | 1 | |
#11 | Norway | 1 | |
#12 | New Zealand | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Machines | |
#3 | Medical technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Unspecified technologies | |
#4 | Dentistry |
# | Name | Total Patents |
---|---|---|
#1 | Weber Eckard | 22 |
#2 | Katz Howard I | 13 |
#3 | Knowles Julius | 8 |
#4 | Chen Andrew X | 7 |
#5 | Julius Knowles | 3 |
#6 | Eckard Weber | 2 |
#7 | Gilad Jack | 1 |
#8 | Stashenko Philip | 1 |
#9 | Andrew X Chen | 1 |
#10 | Rutherford Robert Bruce | 1 |
Publication | Filing date | Title |
---|---|---|
WO2008109124A1 | Use of nitroglycerin to reverse local anesthesia | |
WO2004000219A2 | Stabilized formulations of alpha adrenergic receptor antagonists and uses thereof | |
US7229630B2 | Stabilized formulations of alpha adrenergic receptor antagonists and the uses thereof | |
CN1688312A | Stabilized formulations of alpha adrenergic receptor antagonists and the uses thereof | |
AU5984801A | Local anesthetic methods and kits |